Blood-sugar lowering medications may increase risk for false positive results in cancer screenings
Tuesday, June 8, 2010 - 01:20
in Health & Medicine
A study suggests that medication ingested to control blood-sugar levels can skew the results of cancer screenings using positron emission tomography (PET), a molecular imaging technique, by increasing absorption in the gut of the PET imaging agent called fluorodeoxyglucose (18F-FDG), which mimics sugar inside the body.
